Overview of extracellular vesicles in health and disease

Extracellular Vesicles in Health and Disease

Volumn , Issue , 2014, Pages 1-46

  Nieuwland, Rienk ^a   Van der Pol, Edwin ^a   Sturka, Augueste ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974602087     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4032/9789814411998     Document Type: Chapter

References (256)

1. Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, Valle M, Elortza F, Lu SC, Mato JM, Falcon-Perez JM (2008) Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes, J. Proteome Res., 7(12), 5157-5166.
2. Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia RP, Bertina RM, Osanto S (2010) Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles, J. Thromb. Haemost., 8(2), 315-323.
3. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, Harrison P, Sargent IL (2011) Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis, Nanomedicine, 7(6), 780-788.
4. van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, Nieuwland R (2010) Optical and non-optical methods for detection and characterization of microparticles and exosomes, J. Thromb. Haemost., 8(12), 2596-2607.
5. van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG (2012) Single versus swarm detection of microparticles and exosomes by flow cytometry, J. Thromb. Haemost., 10(5), 919-930.
6. Chargaff E, West R (1946) The biological significance of the thromboplastic protein of blood, J. Biol. Chem., 166(1), 189-197.
7. Wolf P (1967) The nature and significance of platelet products in human plasma, BJH, 13(3), 269-288.
8. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C (1987) Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes), J. Biol. Chem., 262(19), 9412-9420.
9. Johnstone RM, Mathew A, Mason AB, Teng K (1991) Exosome formation during maturation of mammalian and avian reticulocytes evidence that exosome release is a major route for externalization of obsolete membrane proteins, J. Cell Physiol., 147(1), 27-36.
10. Grdisa M, Mathew A, Johnstone RM (1993) Expression and loss of the transferrin receptor in growing and differentiating HD3 cells, J. Cell Physiol., 155(2), 349-357.
11. Johnstone RM (1992) The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins Biochem. Cell Biol., 70(3-4), 179-190.
12. Le Pecq JB (2005) Dexosomes as a therapeutic cancer vaccine: from bench to bedside, Blood Cells Mol. Dis., 35(2), 129-135.
13. Stegmayr B, Ronquist G (1982) Promotive effect on human sperm progressive motility by prostasomes, Urol. Res., 10(5), 253-257.
14. Tanimura A, McGregor DH, Anderson HC (1983) Matrix vesicles in atherosclerotic calcification, Proc. Soc. Exp. Biol. Med., 172(2), 173-177.
15. Fischer von MG, Mignery GA, Baumert M, Perin MS, Hanson TJ, Burger PM, Jahn R, Sudhof TC (1990) rab3 is a small GTP-binding protein exclusively localized to synaptic vesicles, Proc. Natl. Acad. Sci. U. S. A., 87(5), 1988-1992.
16. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles:artefacts no more, Trends Cell Biol., 19(2), 43-51.
17. Thery C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses, Nat. Rev. Immunol., 9(8), 581-593.
18. Beyer C, Pisetsky DS (2010) The role of microparticles in the pathogenesis of rheumatic diseases, Nat. Rev. Rheumatol., 6(1), 21-29.
19. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication, J. Proteomics, 73(10), 1907-1920.
20. Chandler WL, Yeung W, Tait JF (2011) A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer, J. Thromb. Haemost., 9(6), 1216-1224.
21. Dalli J, Norling LV, Renshaw D, Cooper D, Leung KY, Perretti M (2008) Annexin 1 mediates the rapid anti-inflammatory effects of neutrophilderived microparticles, Blood, 112(6), 2512-2519.
22. Walker JD, Maier CL, Pober JS (2009) Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes, J. Immunol., 182(3), 1548-1559.
23. Prado N, Marazuela EG, Segura E, Fernandez-Garcia H, Villalba M, Thery C, Rodriguez R, Batanero E (2008) Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction, J. Immunol., 181(2), 1519-1525.
24. Kesimer M, Scull M, Brighton B, DeMaria G, Burns K, O'Neal W, Pickles RJ, Sheehan JK (2009) Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense, FASEB J., 23(6), 1858-1868.
25. Admyre C, Grunewald J, Thyberg J, Gripenback S, Tornling G, Eklund A, Scheynius A, Gabrielsson S (2003) Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid, Eur. Respir. J., 22(4), 578-583.
26. Pisitkun T, Shen RF, Knepper MA (2004) Identification and proteomic profiling of exosomes in human urine, Proc. Natl. Acad. Sci. U. S. A., 101(36), 13368-13373.
27. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C (2005) Exosomal-like vesicles are present in human blood plasma, Int. Immunol., 17(7), 879-887.
28. Keller S, Sanderson MP, Stoeck A, Altevogt P (2006) Exosomes: from biogenesis and secretion to biological function, Immunol. Lett., 107(2), 102-108.
29. Vella LJ, Greenwood DL, Cappai R, Scheerlinck JP, Hill AF (2008) Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid Vet. Immunol. Immunopathol., 124(3-4), 385-393.
30. Simons M, Raposo G (2009) Exosomes-vesicular carriers for intercellular communication, Curr. Opin. Cell Biol., 21(4), 575-581.
31. Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J, Slot JW, Geuze HJ, Stoorvogel W (2003) Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation, J. Biol. Chem., 278(13), 10963-10972.
32. Chaput N, Thery C (2011) Exosomes: immune properties and potential clinical implementations, Semin. Immunopathol., 33(5), 419-440.
33. Bobrie A, Colombo M, Raposo G, Thery C (2011) Exosome secretion:molecular mechanisms and roles in immune responses, Traffic, 12(12), 1659-1668.
34. Record M, Subra C, Silvente-Poirot S, Poirot M (2011) Exosomes as intercellular signalosomes and pharmacological effectors, Biochem. Pharmacol., 81(10), 1171-1182.
35. Matsuo H, Chevallier J, Mayran N, Le B, I, Ferguson C, Faure J, Blanc NS, Matile S, Dubochet J, Sadoul R, Parton RG, Vilbois F, Gruenberg J (2004) Role of LBPA and Alix in multivesicular liposome formation and endosome organization, Science, 303(5657), 531-534.
36. Mobius W, Ohno-Iwashita Y, van Donselaar EG, Oorschot VM, Shimada Y, Fujimoto T, Heijnen HF, Geuze HJ, Slot JW (2002) Immunoelectron microscopic localization of cholesterol using biotinylated and noncytolytic perfringolysin O, J. Histochem. Cytochem., 50(1), 43-55.
37. White IJ, Bailey LM, Aghakhani MR, Moss SE, Futter CE (2006) EGF stimulates annexin 1-dependent inward vesiculation in a multivesicular endosome subpopulation, EMBO J., 25(1), 1-12.
38. Babst M (2005) A protein's final ESCRT, Traffic, 6(1), 2-9.
39. Michelet X, Djeddi A, Legouis R (2010) Developmental and cellular functions of the ESCRT machinery in pluricellular organisms, Biol. Cell, 102(3), 191-202.
40. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes, Science, 319(5867), 1244-1247.
41. Marsh M, van Meer G (2008) Cell biology. No ESCRTs for exosomes, Science, 319(5867), 1191-1192.
42. Theos AC, Truschel ST, Tenza D, Hurbain I, Harper DC, Berson JF, Thomas PC, Raposo G, Marks MS (2006) A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis, Dev. Cell, 10(3), 343-354.
43. Buschow SI, Nolte-'t Hoen EN, van NG, Pols MS, ten BT, Lauwen M, Ossendorp F, Melief CJ, Raposo G, Wubbolts R, Wauben MH, Stoorvogel W (2009) MHC II in dendritic cells is targeted to lysosomes or T cellinduced exosomes via distinct multivesicular body pathways, Traffic, 10(10), 1528-1542.
44. Savina A, Fader CM, Damiani MT, Colombo MI (2005) Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner, Traffic, 6(2), 131-143.
45. Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, Lauterbach MA, Bakhti M, Gronborg M, Mobius W, Rhee J, Barr FA, Simons M (2010) Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C, J. Cell Biol., 189(2), 223-232.
46. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF, Thery C (2010) Rab27a and Rab27b control different steps of the exosome secretion pathway, Nat. Cell Biol., 12(1), 19-30.
47. Stenmark H (2009) Rab GTPases as coordinators of vesicle traffic, Nat. Rev. Mol. Cell Biol., 10(8), 513-525.
48. Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ (2006) Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane, J. Cell Biol., 172(6), 923-935.
49. Lenassi M, Cagney G, Liao M, Vaupotic T, Bartholomeeusen K, Cheng Y, Krogan NJ, Plemenitas A, Peterlin BM (2010) HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells, Traffic, 11(1), 110-122.
50. Fang Y, Wu N, Gan X, Yan W, Morrell JC, Gould SJ (2007) Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes, PLOS Biol., 5(6), e158.
51. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, ten HK, Eijsman L, Hack CE, Sturk A (1997) Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant, Circulation, 96(10), 3534-3541.
52. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules, Blood, 94(11), 3791-3799.
53. Canault M, Leroyer AS, Peiretti F, Leseche G, Tedgui A, Bonardo B, Alessi MC, Boulanger CM, Nalbone G (2007) Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1, Am. J. Pathol., 171(5), 1713-1723.
54. Berckmans RJ, Nieuwland R, Tak PP, Boing AN, Romijn FP, Kraan MC, Breedveld FC, Hack CE, Sturk A (2002) Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism, Arthritis Rheum., 46(11), 2857-2866.
55. Berckmans RJ, Sturk A, van Tienen LM, Schaap MC, Nieuwland R (2011) Cell-derived vesicles exposing coagulant tissue factor in saliva, Blood, 117(11), 3172-3180.
56. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes, Circulation, 101(8), 841-843.
57. Morel O, Jesel L, Freyssinet JM, Toti F (2011) Cellular mechanisms underlying the formation of circulating microparticles, Arterioscler. Thromb. Vasc. Biol., 31(1), 15-26.
58. Turiak L, Misjak P, Szabo TG, Aradi B, Paloczi K, Ozohanics O, Drahos L, Kittel A, Falus A, Buzas EI, Vekey K (2011) Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice, J. Proteomics, 74(10), 2025-2033.
59. Gyorgy B, Modos K, Pallinger E, Paloczi K, Pasztoi M, Misjak P, Deli MA, Sipos A, Szalai A, Voszka I, Polgar A, Toth K, Csete M, Nagy G, Gay S, Falus A, Kittel A, Buzas EI (2011) Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters, Blood, 117(4), e39-e48.
60. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP (2003) Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes, Blood, 102(7), 2678-2683.
61. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A (2001) Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms, Thromb. Haemost., 85(5), 810-820.
62. Connor DE, Exner T, Ma DD, Joseph JE (2010) The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib, Thromb. Haemost., 103(5), 1044-1052.
63. Marzesco AM, Janich P, Wilsch-Brauninger M, Dubreuil V, Langenfeld K, Corbeil D, Huttner WB (2005) Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells J. Cell Sci., 118(Pt 13), 2849-2858.
64. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer, 26(4), 239-257.
65. Hristov M, Erl W, Linder S, Weber PC (2004) Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro, Blood, 104(9), 2761-2766.
66. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles, J. Immunol., 166(12), 7309-7318.
67. Bilyy RO, Shkandina T, Tomin A, Munoz LE, Franz S, Antonyuk V, Kit YY, Zirngibl M, Fuernrohr BG, Janko C, Lauber K, Schiller M, Schett G, Stoika RS, Herrmann M (2011) Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles, J. Biol. Chem., 287(1), 496-503.
68. Martinez-Lorenzo MJ, Anel A, Gamen S, Monlen I, Lasierra P, Larrad L, Pineiro A, Alava MA, Naval J (1999) Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles, J. Immunol., 163(3), 1274-1281.
69. Hohlbaum AM, Gregory MS, Ju ST, Marshak-Rothstein A (2001) Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors, J. Immunol., 167(11), 6217-6224.
70. Abrahams VM, Straszewski-Chavez SL, Guller S, Mor G (2004) First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis, Mol. Hum. Reprod., 10(1), 55-63.
71. Frangsmyr L, Baranov V, Nagaeva O, Stendahl U, Kjellberg L, Mincheva-Nilsson L (2005) Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level, Mol. Hum. Reprod., 11(1), 35-41.
72. Taylor DD, Akyol S, Gercel-Taylor C (2006) Pregnancy-associated exosomes and their modulation of T cell signaling, J. Immunol., 176(3), 1534-1542.
73. Hedlund M, Stenqvist AC, Nagaeva O, Kjellberg L, Wulff M, Baranov V, Mincheva-Nilsson L (2009) Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function, J. Immunol., 183(1), 340-351.
74. Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, Squarcina P, Accornero P, Lozupone F, Lugini L, Stringaro A, Molinari A, Arancia G, Gentile M, Parmiani G, Fais S (2002) Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles, J. Exp. Med., 195(10), 1303-1316.
75. Martinez-Lorenzo MJ, Anel A, Alava MA, Pineiro A, Naval J, Lasierra P, Larrad L (2004) The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack, Exp. Cell Res., 295(2), 315-329.
76. Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL, Min WP (2005) Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis, Blood Cells Mol. Dis., 35(2), 169-173.
77. Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, Mor G (2003) Epithelial ovarian cancer cells secrete functional Fas ligand, Cancer Res., 63(17), 5573-5581.
78. Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL (2005) Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes, Clin. Cancer Res., 11(3), 1010-1020.
79. Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, Zhang HG (2006) Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function, J. Immunol., 176(3), 1375-1385.
80. Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z (2008) Human tumor-derived exosomes down-modulate NKG2D expression, J. Immunol., 180(11), 7249-7258.
81. Hedlund M, Nagaeva O, Kargl D, Baranov V, Mincheva-Nilsson L (2011) Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells, PLOS ONE, 6(2), e16899.
82. Liu Y, Xiang X, Zhuang X, Zhang S, Liu C, Cheng Z, Michalek S, Grizzle W, Zhang HG (2010) Contribution of MyD88 to the tumor exosomemediated induction of myeloid derived suppressor cells, Am. J. Pathol., 176(5), 2490-2499.
83. Xiang X, Poliakov A, Liu C, Liu Y, Deng ZB, Wang J, Cheng Z, Shah SV, Wang GJ, Zhang L, Grizzle WE, Mobley J, Zhang HG (2009) Induction of myeloid-derived suppressor cells by tumor exosomes, Int. J. Cancer, 124(11), 2621-2633.
84. Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z (2011) Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production, J. Immunol., 187(2), 676-683.
85. Flanagan J, Middeldorp J, Sculley T (2003) Localization of the Epstein-Barr virus protein LMP 1 to exosomes J. Gen. Virol., 84(Pt 7), 1871-1879.
86. Silverman JM, Clos J, Horakova E, Wang AY, Wiesgigl M, Kelly I, Lynn MA, McMaster WR, Foster LJ, Levings MK, Reiner NE (2010) Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells, J. Immunol., 185(9), 5011-5022.
87. Silverman JM, Clos J, de'Oliveira CC, Shirvani O, Fang Y, Wang C, Foster LJ, Reiner NE (2010) An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages J. Cell Sci., 123(Pt 6), 842-852.
88. Zhang HG, Liu C, Su K, Yu S, Zhang L, Zhang S, Wang J, Cao X, Grizzle W, Kimberly RP (2006) A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death, J. Immunol., 176(12), 7385-7393.
89. van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, Heyman M (2001) Intestinal epithelial cells secrete exosome-like vesicles, Gastroenterology, 121(2), 337-349.
90. van, Niel G, Mallegol J, Bevilacqua C, Candalh C, Brugiere S, Tomaskovic-Crook E, Heath JK, Cerf-Bensussan N, Heyman M (2003) Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice, Gut, 52(12), 1690-1697.
91. Almqvist N, Lonnqvist A, Hultkrantz S, Rask C, Telemo E (2008) Serumderived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma, Immunology, 125(1), 21-27.
92. Admyre C, Bohle B, Johansson SM, Focke-Tejkl M, Valenta R, Scheynius A, Gabrielsson S (2007) B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines, J. Allergy Clin. Immunol., 120(6), 1418-1424.
93. Segura E, Guerin C, Hogg N, Amigorena S, Thery C (2007) CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo, J. Immunol., 179(3), 1489-1496.
94. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming, Nat. Med., 7(3), 297-303.
95. Andre F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu DH, Tursz T, Amigorena S, Angevin E, Zitvogel L (2004) Exosomes as potent cell-free peptidebased vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells, J. Immunol., 172(4), 2126-2136.
96. Beauvillain C, Juste MO, Dion S, Pierre J, Dimier-Poisson I (2009) Exosomes are an effective vaccine against congenital toxoplasmosis in mice, Vaccine, 27(11), 1750-1757.
97. Beauvillain C, Ruiz S, Guiton R, Bout D, Dimier-Poisson I (2007) A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice Microbes Infect., 9(14-15), 1614-1622.
98. Aline F, Bout D, Amigorena S, Roingeard P, Dimier-Poisson I (2004) Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection, Infect. Immun., 72(7), 4127-4137.
99. Schnitzer JK, Berzel S, Fajardo-Moser M, Remer KA, Moll H (2010) Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major, Vaccine, 28(36), 5785-5793.
100. Ramachandra L, Qu Y, Wang Y, Lewis CJ, Cobb BA, Takatsu K, Boom WH, Dubyak GR, Harding CV (2010) Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation, Infect. Immun., 78(12), 5116-5125.
101. Anand PK, Anand E, Bleck CK, Anes E, Griffiths G (2010) Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria, PLOS ONE, 5(4), e10136.
102. Del Cacho E, Gallego M, Lee SH, Lillehoj HS, Quilez J, Lillehoj EP, Sanchez-Acedo C (2011) Induction of protective immunity against Eimeria tenella infection using antigen-loaded dendritic cells (DC) and DC-derived exosomes, Vaccine, 29(21), 3818-3825.
103. Fourcade O, Simon MF, Viode C, Rugani N, Leballe F, Ragab A, Fournie B, Sarda L, Chap H (1995) Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells, Cell, 80(6), 919-927.
104. Barry OP, Pratico D, Savani RC, FitzGerald GA (1998) Modulation of monocyte-endothelial cell interactions by platelet microparticles, J. Clin. Invest, 102(1), 136-144.
105. Park KH, Kim BJ, Kang J, Nam TS, Lim JM, Kim HT, Park JK, Kim YG, Chae SW, Kim UH (2011) Ca2+ signaling tools acquired from prostasomes are required for progesterone-induced sperm motility, Sci. Signal, 4(173), ra31.
106. Ren D (2011) Calcium signaling in sperm: help from prostasomes, Sci. Signal, 4(173), e27.
107. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ (2010) Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling, J. Cell Biol., 190(6), 1079-1091.
108. Khan S, Jutzy JM, Aspe JR, McGregor DW, Neidigh JW, Wall NR (2011) Survivin is released from cancer cells via exosomes, Apoptosis, 16(1), 1-12.
109. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW (2007) Systemic inflammatory priming in normal pregnancy and preeclampsia:the role of circulating syncytiotrophoblast microparticles, J. Immunol., 178(9), 5949-5956.
110. Messerli M, May K, Hansson SR, Schneider H, Holzgreve W, Hahn S, Rusterholz C (2010) Feto-maternal interactions in pregnancies:placental microparticles activate peripheral blood monocytes, Placenta, 31(2), 106-112.
111. Southcombe J, Tannetta D, Redman C, Sargent I (2011) The immunomodulatory role of syncytiotrophoblast microvesicles, PLOS ONE, 6(5), e20245.
112. Berckmans RJ, Nieuwland R, Kraan MC, Schaap MC, Pots D, Smeets TJ, Sturk A, Tak PP (2005) Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes, Arthritis Res. Ther., 7(3), R536-R544.
113. Distler JH, Jungel A, Huber LC, Seemayer CA, Reich CF, III, Gay RE, Michel BA, Fontana A, Gay S, Pisetsky DS, Distler O (2005) The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles, Proc. Natl. Acad. Sci. U. S. A., 102(8), 2892-2897.
114. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, Lee DM (2010) Platelets amplify inflammation in arthritis via collagendependent microparticle production, Science, 327(5965), 580-583.
115. Distler JH, Distler O (2010) Inflammation: microparticles and their roles in inflammatory arthritides, Nat. Rev. Rheumatol., 6(7), 385-386.
116. Cerri C, Chimenti D, Conti I, Neri T, Paggiaro P, Celi A (2006) Monocyte/ macrophage-derived microparticles up-regulate inflammatory mediator synthesis by human airway epithelial cells, J. Immunol., 177(3), 1975-1980.
117. Rautou PE, Leroyer AS, Ramkhelawon B, Devue C, Duflaut D, Vion AC, Nalbone G, Castier Y, Leseche G, Lehoux S, Tedgui A, Boulanger CM (2011) Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration, Circ. Res., 108(3), 335-343.
118. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A (2001) Rapid secretion of interleukin-1beta by microvesicle shedding, Immunity, 15(5), 825-835.
119. Wilson HL, Francis SE, Dower SK, Crossman DC (2004) Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation, J. Immunol., 173(2), 1202-1208.
120. Bianco F, Pravettoni E, Colombo A, Schenk U, Moller T, Matteoli M, Verderio C (2005) Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia, J. Immunol., 174(11), 7268-7277.
121. Wang JG, Williams JC, Davis BK, Jacobson K, Doerschuk CM, Ting JP, Mackman N (2011) Monocytic microparticles activate endothelial cells in an IL-1beta-dependent manner, Blood, 118(8), 2366-2374.
122. Thomas LM, Salter RD (2010) Activation of macrophages by P2X7- induced microvesicles from myeloid cells is mediated by phospholipids and is partially dependent on TLR4, J. Immunol., 185(6), 3740-3749.
123. Esser J, Gehrmann U, D'Alexandri FL, Hidalgo-Estevez AM, Wheelock CE, Scheynius A, Gabrielsson S, Radmark O (2010) Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration, J. Allergy Clin. Immunol., 126(5), 1032-1040.
124. Deng ZB, Poliakov A, Hardy RW, Clements R, Liu C, Liu Y, Wang J, Xiang X, Zhang S, Zhuang X, Shah SV, Sun D, Michalek S, Grizzle WE, Garvey T, Mobley J, Zhang HG (2009) Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance, Diabetes, 58(11), 2498-2505.
125. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, Nat. Cell Biol., 10(5), 619-624.
126. Higginbotham JN, Demory BM, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, Piston DW, Ayers GD, McConnell RE, Tyska MJ, Coffey RJ (2011) Amphiregulin exosomes increase cancer cell invasion, Curr. Biol., 21(9), 779-786.
127. Tourneur L, Mistou S, Schmitt A, Chiocchia G (2008) Adenosine receptors control a new pathway of Fas-associated death domain protein expression regulation by secretion, J. Biol. Chem., 283(26), 17929-17938.
128. Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, Morelli D, Villa A, Mina PD, Menard S, Filipazzi P, Rivoltini L, Tagliabue E, Pupa SM (2012) Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy, J. Cell Physiol., 227(2), 658-667.
129. Gong J, Jaiswal R, Mathys JM, Combes V, Grau GE, Bebawy M (2011) Microparticles and their emerging role in cancer multidrug resistance, Cancer Treat. Rev., 38(3), 226-234.
130. Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W, Howell SB (2005) Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells, Mol. Cancer Ther., 4(10), 1595-1604.
131. Sheldon H, Heikamp E, Turley H, Dragovic R, Thomas P, Oon CE, Leek R, Edelmann M, Kessler B, Sainson RC, Sargent I, Li JL, Harris AL (2010) New mechanism for Notch signaling to endothelium at a distance by delta-like 4 incorporation into exosomes, Blood, 116(13), 2385-2394.
132. Hakulinen J, Sankkila L, Sugiyama N, Lehti K, Keski-Oja J (2008) Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes, J. Cell Biochem., 105(5), 1211-1218.
133. Taverna S, Flugy A, Saieva L, Kohn EC, Santoro A, Meraviglia S, De LG, Alessandro R (2011) Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis, Int. J. Cancer, 130(9), 2033-2043.
134. Uno K, Homma S, Satoh T, Nakanishi K, Abe D, Matsumoto K, Oki A, Tsunoda H, Yamaguchi I, Nagasawa T, Yoshikawa H, Aonuma K (2007) Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer, Br. J. Cancer, 96(2), 290-295.
135. Zoller M (2009) Tetraspanins: push and pull in suppressing and promoting metastasis, Nat. Rev. Cancer, 9(1), 40-55.
136. Peinado H, Lavotshkin S, Lyden D (2011) The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts, Semin. Cancer Biol., 21(2), 139-146.
137. Rak J (2010) Microparticles in cancer, Semin. Thromb. Haemost., 36(8), 888-906.
138. Martinez MC, Larbret F, Zobairi F, Coulombe J, Debili N, Vainchenker W, Ruat M, Freyssinet JM (2006) Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens, Blood, 108(9), 3012-3020.
139. Yaron S, Kolling GL, Simon L, Matthews KR (2000) Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria, Appl. Environ. Microbiol., 66(10), 4414-4420.
140. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat. Cell Biol., 9(6), 654-659.
141. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, Gonzalez S, Sanchez-Cabo F, Gonzalez MA, Bernad A, Sanchez-Madrid F (2011) Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells, Nat. Commun., 2282.
142. Montecalvo A, Larregina AT, Shufesky WJ, Beer SD, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z, Milosevic J, Tkacheva OA, Divito SJ, Jordan R, Lyons-Weiler J, Watkins SC, Morelli AE (2011) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes, Blood, 119(3), 756-766.
143. Skog J, Wurdinger T, van RS, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Jr., Carter BS, Krichevsky AM, Breakefield XO (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nat. Cell Biol., 10(12), 1470-1476.
144. Hong BS, Cho JH, Kim H, Choi EJ, Rho S, Kim J, Kim JH, Choi DS, Kim YK, Hwang D, Gho YS (2009) Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells, BMC Genomics, 10556.
145. Guescini M, Genedani S, Stocchi V, Agnati LF (2010) Astrocytes and glioblastoma cells release exosomes carrying mtDNA, J. Neural Transm., 117(1), 1-4.
146. Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J (2011) Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences, Nat. Commun., 2180.
147. Lasser C, Alikhani VS, Ekstrom K, Eldh M, Paredes PT, Bossios A, Sjostrand M, Gabrielsson S, Lotvall J, Valadi H (2011) Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages, J. Transl. Med., 9, 9.
148. Meckes DG, Jr., Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N (2010) Human tumor virus utilizes exosomes for intercellular communication, Proc. Natl. Acad. Sci. U. S. A., 107(47), 20370-20375.
149. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Wurdinger T, Middeldorp JM (2010) Functional delivery of viral miRNAs via exosomes, Proc. Natl. Acad. Sci. U. S. A., 107(14), 6328-6333.
150. Gourzones C, Gelin A, Bombik I, Klibi J, Verillaud B, Guigay J, Lang P, Temam S, Schneider V, Amiel C, Baconnais S, Jimenez AS, Busson P (2010) Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells, Virol. J., 7, 271.
151. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, Laude H, Raposo G (2004) Cells release prions in association with exosomes, Proc. Natl. Acad. Sci. U. S. A., 101(26), 9683-9688.
152. Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF (2007) Packaging of prions into exosomes is associated with a novel pathway of PrP processing, J. Pathol., 211(5), 582-590.
153. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, Simons K (2006) Alzheimer's disease beta-amyloid peptides are released in association with exosomes, Proc. Natl. Acad. Sci. U. S. A., 103(30), 11172-11177.
154. Mack M, Kleinschmidt A, Bruhl H, Klier C, Nelson PJ, Cihak J, Plachy J, Stangassinger M, Erfle V, Schlondorff D (2000) Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection, Nat. Med., 6(7), 769-775.
155. Rozmyslowicz T, Majka M, Kijowski J, Murphy SL, Conover DO, Poncz M, Ratajczak J, Gaulton GN, Ratajczak MZ (2003) Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV, AIDS, 17(1), 33-42.
156. Wiley RD, Gummuluru S (2006) Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection, Proc. Natl. Acad. Sci. U. S. A., 103(3), 738-743.
157. Krishnamoorthy L, Bess JW, Jr., Preston AB, Nagashima K, Mahal LK (2009) HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin, Nat. Chem. Biol., 5(4), 244-250.
158. Shelton MN, Huang MB, Ali SA, Powell MD, Bond VC (2012) SMRderived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release, J. Virol., 86(1), 406-419.
159. Raymond AD, Campbell-Sims TC, Khan M, Lang M, Huang MB, Bond VC, Powell MD (2011) HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals, AIDS Res. Hum. Retroviruses, 27(2), 167-178.
160. Meckes DG, Jr., Raab-Traub N (2011) Microvesicles and viral infection, J. Virol., 85(24), 12844-12854.
161. Gould SJ, Booth AM, Hildreth JE (2003) The Trojan exosome hypothesis, Proc. Natl. Acad. Sci. U. S. A., 100(19), 10592-10597.
162. Gan X, Gould SJ (2011) Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins, Mol. Biol. Cell, 22(6), 817-830.
163. Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Krausslich HG (2006) The HIV lipidome: a raft with an unusual composition, Proc. Natl. Acad. Sci. U. S. A., 103(8), 2641-2646.
164. Izquierdo-Useros N, Naranjo-Gomez M, Archer J, Hatch SC, Erkizia I, Blanco J, Borras FE, Puertas MC, Connor JH, Fernandez-Figueras MT, Moore L, Clotet B, Gummuluru S, Martinez-Picado J (2009) Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway, Blood, 113(12), 2732-2741.
165. Sato K, Aoki J, Misawa N, Daikoku E, Sano K, Tanaka Y, Koyanagi Y (2008) Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins, J. Virol., 82(2), 1021-1033.
166. Jolly C, Sattentau QJ (2007) Human immunodeficiency virus type 1 assembly, budding, cell-cell spread in T cells take place in tetraspaninenriched plasma membrane domains, J. Virol., 81(15), 7873-7884.
167. Tumne A, Prasad VS, Chen Y, Stolz DB, Saha K, Ratner DM, Ding M, Watkins SC, Gupta P (2009) Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD8+ T cells, J. Virol., 83(9), 4354-4364.
168. Khatua AK, Taylor HE, Hildreth JE, Popik W (2010) Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F, Virology, 400(1), 68-75.
169. Khatua AK, Taylor HE, Hildreth JE, Popik W (2009) Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells, J. Virol., 83(2), 512-521.
170. Merten M, Pakala R, Thiagarajan P, Benedict CR (1999) Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism, Circulation, 99(19), 2577-2582.
171. Kadurugamuwa JL, Beveridge TJ (1999) Membrane vesicles derived from Pseudomonas aeruginosa and Shigella flexneri can be integrated into the surfaces of other gram-negative bacteria Microbiology, 145(Pt 8), 2051-2060.
172. Kadurugamuwa JL, Beveridge TJ (1998) Delivery of the nonmembrane- permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles, Antimicrob. Agents Chemother., 42(6), 1476-1483.
173. Johnstone RM, Bianchini A, Teng K (1989) Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions, Blood, 74(5), 1844-1851.
174. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ (1988) Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity, J. Biol. Chem., 263(34), 18205-18212.
175. de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M (2003) Lipid raft-associated protein sorting in exosomes, Blood, 102(13), 4336-4344.
176. Abid Hussein MN, Nieuwland R, Hau CM, Evers LM, Meesters EW, Sturk A (2005) Cell-derived microparticles contain caspase 3 in vitro and in vivo, J. Thromb. Haemost., 3(5), 888-896.
177. Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR (2003) Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles, Cancer Res., 63(15), 4331-4337.
178. Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM, Carvalho AC (1981) Tumor shedding and coagulation, Science, 212(4497), 923-924.
179. Bastida E, Ordinas A, Escolar G, Jamieson GA (1984) Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, thrombogenesis, Blood, 64(1), 177-184.
180. Tesselaar ME, Romijn FP, van der Linden IK, Prins FA, Bertina RM, Osanto S (2007) Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J. Thromb. Haemost., 5(3), 520-527.
181. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B (2009) Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy, Clin. Cancer Res., 15(22), 6830-6840.
182. Hugel B, Socie G, Vu T, Toti F, Gluckman E, Freyssinet JM, Scrobohaci ML (1999) Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia, Blood, 93(10), 3451-3456.
183. Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ (1993) Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria, Blood, 82(4), 1192-1196.
184. Babiker AA, Ronquist G, Nilsson UR, Nilsson B (2002) Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis, Am. J. Reprod. Immunol., 47(3), 183-192.
185. Dachary-Prigent J, Pasquet JM, Fressinaud E, Toti F, Freyssinet JM, Nurden AT (1997) Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics, BJH, 99(4), 959-967.
186. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A (2000) Cellular origin and procoagulant properties of microparticles in meningococcal sepsis, Blood, 95(3), 930-935.
187. Biro E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R (2003) Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner, J. Thromb. Haemost., 1(12), 2561-2568.
188. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity, Circulation, 99(3), 348-353.
189. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA (2005) Tissuefactor- bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation, Blood, 106(5), 1604-1611.
190. Furie B, Furie BC (2004) Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation, Trends Mol. Med., 10(4), 171-178.
191. Furie B, Furie BC (2008) Mechanisms of thrombus formation, N. Engl. J. Med., 359(9), 938-949.
192. Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, Sturk A (2001) Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation, Thromb. Haemost., 85(4), 639-646.
193. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH (1991) Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles, Blood, 77(12), 2641-2648.
194. Dahlback B, Wiedmer T, Sims PJ (1992) Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles, Biochemistry, 31(51), 12769-12777.
195. Laulagnier K, Motta C, Hamdi S, Roy S, Fauvelle F, Pageaux JF, Kobayashi T, Salles JP, Perret B, Bonnerot C, Record M (2004) Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization Biochem. J., 380(Pt 1), 161-171.
196. VanWijk MJ, Svedas E, Boer K, Nieuwland R, Vanbavel E, Kublickiene KR (2002) Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women, Am. J. Obstet. Gynecol., 187(6), 1686-1693.
197. Martin S, Tesse A, Hugel B, Martinez MC, Morel O, Freyssinet JM, Andriantsitohaina R (2004) Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression, Circulation, 109(13), 1653-1659.
198. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le CT, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L (2002) Malignant effusions and immunogenic tumour-derived exosomes, Lancet, 360(9329), 295-305.
199. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, Nat. Med., 4(5), 594-600.
200. Thery C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, Raposo G, Amigorena S (1999) Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73, J. Cell Biol., 147(3), 599-610.
201. Johansson SM, Admyre C, Scheynius A, Gabrielsson S (2008) Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes, Immunology, 123(4), 491-499.
202. Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, Ruegg C, Le Pecq JB (2002) Production and characterization of clinical grade exosomes derived from dendritic cells, J. Immunol. Methods, 270(2), 211-226.
203. Viaud S, Ploix S, Lapierre V, Thery C, Commere PH, Tramalloni D, Gorrichon K, Virault-Rocroy P, Tursz T, Lantz O, Zitvogel L, Chaput N (2011) Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferongamma, J. Immunother., 34(1), 65-75.
204. Chaput N, Schartz NE, Andre F, Taieb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, Adema G, Adams M, Ferrantini M, Carpentier AF, Escudier B, Tursz T, Angevin E, Zitvogel L (2004) Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection, J. Immunol., 172(4), 2137-2146.
205. Adams M, Navabi H, Croston D, Coleman S, Tabi Z, Clayton A, Jasani B, Mason MD (2005) The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer Vaccine, 23(17-18), 2374-2378.
206. Dai S, Wan T, Wang B, Zhou X, Xiu F, Chen T, Wu Y, Cao X (2005) More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells, Clin. Cancer Res., 11(20), 7554-7563.
207. Chen W, Wang J, Shao C, Liu S, Yu Y, Wang Q, Cao X (2006) Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells, Eur. J. Immunol., 36(6), 1598-1607.
208. Chen T, Guo J, Yang M, Zhu X, Cao X (2011) Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raftdependent pathway and act as efficient tumor vaccine, J. Immunol., 186(4), 2219-2228.
209. Taieb J, Chaput N, Schartz N, Roux S, Novault S, Menard C, Ghiringhelli F, Terme M, Carpentier AF, Darrasse-Jeze G, Lemonnier F, Zitvogel L (2006) Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines, J. Immunol., 176(5), 2722-2729.
210. Yang Y, Xiu F, Cai Z, Wang J, Wang Q, Fu Y, Cao X (2007) Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells, J. Cancer Res. Clin. Oncol., 133(6), 389-399.
211. Zhang Y, Luo CL, He BC, Zhang JM, Cheng G, Wu XH (2010) Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma, Int. J. Oncol., 36(1), 133-140.
212. Hartman ZC, Wei J, Glass OK, Guo H, Lei G, Yang XY, Osada T, Hobeika A, Delcayre A, Le Pecq JB, Morse MA, Clay TM, Lyerly HK (2011) Increasing vaccine potency through exosome antigen targeting, Vaccine, 29(50), 9361-9367.
213. Rountree RB, Mandl SJ, Nachtwey JM, Dalpozzo K, Do L, Lombardo JR, Schoonmaker PL, Brinkmann K, Dirmeier U, Laus R, Delcayre A (2011) Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy, Cancer Res., 71(15), 5235-5244.
214. Altieri SL, Khan AN, Tomasi TB (2004) Exosomes from plasmacytoma cells as a tumor vaccine, J. Immunother., 27(4), 282-288.
215. Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, Hsu DH, Le Pecq JB, Lyerly HK (2005) A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer, J. Transl. Med., 3(1), 9.
216. Escudier B, Dorval T, Chaput N, Andre F, Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, Boccaccio C, Bonnerot C, Dhellin O, Movassagh M, Piperno S, Robert C, Serra V, Valente N, Le Pecq JB, Spatz A, Lantz O, Tursz T, Angevin E, Zitvogel L (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial, J. Transl. Med., 3(1), 10.
217. Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G (2008) Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer, Mol. Ther., 16(4), 782-790.
218. van den Boorn JG, Schlee M, Coch C, Hartmann G (2011) SiRNA delivery with exosome nanoparticles, Nat. Biotechnol., 29(4), 325-326.
219. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nat. Biotechnol., 29(4), 341-345.
220. Lakhal S, Wood MJ (2011) Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers, Bioessays, 33(10), 737-741.
221. Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD (2007) Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4, J. Immunol., 179(4), 2242-2249.
222. Kim SH, Bianco N, Menon R, Lechman ER, Shufesky WJ, Morelli AE, Robbins PD (2006) Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive, Mol. Ther., 13(2), 289-300.
223. Bianco NR, Kim SH, Ruffner MA, Robbins PD (2009) Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models, Arthritis Rheum., 60(2), 380-389.
224. Kim SH, Lechman ER, Bianco N, Menon R, Keravala A, Nash J, Mi Z, Watkins SC, Gambotto A, Robbins PD (2005) Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collageninduced arthritis, J. Immunol., 174(10), 6440-6448.
225. Miksa M, Wu R, Dong W, Komura H, Amin D, Ji Y, Wang Z, Wang H, Ravikumar TS, Tracey KJ, Wang P (2009) Immature dendritic cellderived exosomes rescue septic animals via milk fat globule epidermal growth factor-factor VIII [corrected], J. Immunol., 183(9), 5983-5990.
226. Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, Millay M, Ito A, Liu T, Kamide C, Agrawal H, Perlman H, Qin G, Kishore R, Losordo DW (2011) Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity, Circ. Res., 109(7), 724-728.
227. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM, Pasterkamp G, de Kleijn DP, Lim SK (2010) Exosome secreted by MSC reduces myocardial ischemia/ reperfusion injury, Stem Cell Res., 4(3), 214-222.
228. Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson RC (1995) Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor, Lancet, 346(8981), 1004-1005.
229. Carr JM, Dvorak AM, Dvorak HF (1985) Circulating membrane vesicles in leukemic blood Cancer Res., 45(11 Pt 2), 5944-5951.
230. Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S, Jackson B, McKee AC, Alvarez VE, Lee NC, Hall GF (2012) Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid (CSF) in early Alzheimer's Disease, J. Biol. Chem., 287(6), 3842-3849.
231. Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, Tabi Z, Clayton A (2009) Can urinary exosomes act as treatment response markers in prostate cancer?, J. Transl. Med., 7, 4.
232. Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ (2009) Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer, BMC Cancer, 9, 244.
233. Tavoosidana G, Ronquist G, Darmanis S, Yan J, Carlsson L, Wu D, Conze T, Ek P, Semjonow A, Eltze E, Larsson A, Landegren UD, Kamali-Moghaddam M (2011) Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer, Proc. Natl. Acad. Sci. U. S. A., 108(21), 8809-8814.
234. Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, Zhou Q, Sui SF (2010) Cellular internalization of exosomes occurs through phagocytosis, Traffic, 11(5), 675-687.
235. Dasgupta SK, Abdel-Monem H, Niravath P, Le A, Bellera RV, Langlois K, Nagata S, Rumbaut RE, Thiagarajan P (2009) Lactadherin and clearance of platelet-derived microvesicles, Blood, 113(6), 1332-1339.
236. Lopez-Berestein G, Kasi L, Rosenblum MG, Haynie T, Jahns M, Glenn H, Mehta R, Mavligit GM, Hersh EM (1984) Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer, Cancer Res., 44(1), 375-378.
237. Rand ML, Wang H, Bang KW, Packham MA, Freedman J (2006) Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits, J. Thromb. Haemost., 4(7), 1621-1623.
238. Rank A, Nieuwland R, Crispin A, Grutzner S, Iberer M, Toth B, Pihusch R (2011) Clearance of platelet microparticles in vivo, Platelets., 22(2), 111-116.
239. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, Takizawa T, Shigihara T, Goto T, Izumi A, Ohkuchi A, Matsubara S, Takeshita T, Takizawa T (2009) Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes, Biol. Reprod., 81(4), 717-729.
240. van den Goor JM, Nieuwland R, Rutten PM, Tijssen JG, Hau C, Sturk A, Eijsman L, de Mol BA (2007) Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass, Eur. J. Cardiothorac. Surg., 31(6), 1029-1036.
241. Kadurugamuwa JL, Beveridge TJ (1995) Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion, J. Bacteriol., 177(14), 3998-4008.
242. Rivera J, Cordero RJ, Nakouzi AS, Frases S, Nicola A, Casadevall A (2010) Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins, Proc. Natl. Acad. Sci. U. S. A., 107(44), 19002-19007.
243. Mashburn-Warren L, McLean RJ, Whiteley M (2008) Gram-negative outer membrane vesicles: beyond the cell surface, Geobiology, 6(3), 214-219.
244. Mashburn LM, Whiteley M (2005) Membrane vesicles traffic signals and facilitate group activities in a prokaryote, Nature, 437(7057), 422-425.
245. Winans SC (2005) Microbiology: bacterial speech bubbles, Nature, 437(7057), 330.
246. Bomberger JM, Maceachran DP, Coutermarsh BA, Ye S, O'Toole GA, Stanton BA (2009) Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles, PLOS Pathog., 5(4), e1000382.
247. Chen DJ, Osterrieder N, Metzger SM, Buckles E, Doody AM, DeLisa MP, Putnam D (2010) Delivery of foreign antigens by engineered outer membrane vesicle vaccines, Proc. Natl. Acad. Sci. U. S. A., 107(7), 3099-3104.
248. Chutkan H, Kuehn MJ (2011) Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heatlabile enterotoxin, Infect. Immun., 79(9), 3760-3769.
249. Kaparakis M, Turnbull L, Carneiro L, Firth S, Coleman HA, Parkington HC, Le BL, Karrar A, Viala J, Mak J, Hutton ML, Davies JK, Crack PJ, Hertzog PJ, Philpott DJ, Girardin SE, Whitchurch CB, Ferrero RL (2010) Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells, Cell Microbiol., 12(3), 372-385.
250. Kadurugamuwa JL, Beveridge TJ (1996) Bacteriolytic effect of membrane vesicles from Pseudomonas aeruginosa on other bacteria including pathogens: conceptually new antibiotics, J. Bacteriol., 178(10), 2767-2774.
251. Kadurugamuwa JL, Mayer A, Messner P, Sara M, Sleytr UB, Beveridge TJ (1998) S-layered Aneurinibacillus and Bacillus spp. are susceptible to the lytic action of Pseudomonas aeruginosa membrane vesicles, J. Bacteriol., 180(9), 2306-2311.
252. Bjune G, Hoiby EA, Gronnesby JK, Arnesen O, Fredriksen JH, Halstensen A, Holten E, Lindbak AK, Nokleby H, Rosenqvist E, (1991) Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway, Lancet, 338(8775), 1093-1096.
253. Sadarangani M, Pollard AJ (2010) Serogroup B meningococcal vaccines-an unfinished story, Lancet Infect. Dis., 10(2), 112-124.
254. Caron F, du Chatelet IP, Leroy JP, Ruckly C, Blanchard M, Bohic N, Massy N, Morer I, Floret D, Delbos V, Hong E, Revillion M, Berthelot G, Lemee L, Deghmane AE, Benichou J, Levy-Bruhl D, Taha MK (2011) From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak, Lancet Infect. Dis., 11(6), 455-463.
255. van der Ley P, van den Dobbelsteen G (2011) Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants, Hum. Vaccin., 7(8), 886-890.
256. Alaniz RC, Deatherage BL, Lara JC, Cookson BT (2007) Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo, J. Immunol., 179(11), 7692-7701.